Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

Peace James H.; Medeiros Felipe A.; Martin Keith R.; Vittitow Jason L.; Weinreb Robert N.

首页> 外文期刊>Investigative ophthalmology & visual science >Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

【24h】

Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

机译：Latanoprostene BUNOD的功效0.024％对蒂莫尔MALEATE的0.5％用于开放角度青光眼或眼高血压患者的眼内压力下降：月球研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2016年第12期|共3页
作者
Peace James H.; Medeiros Felipe A.; Martin Keith R.; Vittitow Jason L.; Weinreb Robert N.;
展开▼
作者单位

United Med Res Inst Inglewood CA USA;

Univ Calif San Diego Shiley Eye Inst Hamilton Glaucoma Ctr La Jolla CA 92093 USA;

Addenbrookes Hosp Eye Dept Cambridge England;

Bausch Lomb Clin Affairs Bridgewater NJ USA;

Univ Calif San Diego Shiley Eye Inst Hamilton Glaucoma Ctr La Jolla CA 92093 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
入库时间 2022-08-19 17:12:46

相似文献

外文文献
专利

1. Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study [J] . Peace James H., Medeiros Felipe A., Martin Keith R., Investigative ophthalmology & visual science . 2016,第12期

机译：Latanoprostene BUNOD的功效0.024％对蒂莫尔MALEATE的0.5％用于开放角度青光眼或眼高血压患者的眼内压力下降：月球研究
2. Integrated Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies [J] . Kaufman Paul L., Liebmann Jeffrey M., Vittitow Jason L., Investigative ophthalmology & visual science . 2016,第12期

机译：拉坦前列蛋白兔子综合疗效0.024％对蒂莫尔马来酸的0.5％，用于开放角度青光眼或眼高血压患者的眼内压降低：阿波罗和月球研究
3. Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies [J] . Vittitow Jason L., Liebmann Jeffrey M., Kaufman Paul L., Investigative ophthalmology & visual science . 2016,第12期

机译：Latanoprostene Bueod的长期疗效和安全性0.024％，用于开口角度青光眼或眼高血压患者的眼内压力降低：阿波罗和月球研究
4. Changes in Intraocular Pressure, Ocular Perfusion Pressure and Blood Flow Fluctuations during Dorzolamide vs Timolol Add-on Therapies in Glaucoma Patients Previously Treated with Prostaglandin Analogue [C] . Siaudvytyte L., Januleviciene I., Barsauskaite R., International Symposium on Ocular Pharmacology and Therapeutics . 2011

机译：含有前列腺素患者的多唑胺患者中的眼内压，眼灌注压力和血流波动的变化，前列腺素相似
5. Vascular and morphological changes of the optic nerve head following therapeutic intraocular pressure reduction in open angle glaucoma and ocular hypertension. [D] . Hafez, Ali S. 2007

机译：在开角型青光眼和高眼压的治疗性眼内压降低后，视神经乳头的血管和形态变化。
6. Comparative evaluation of Latanoprostene Bunod Timolol Maleate and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma [O] . Yulong Wang, Yue Liao, Xin Nie 2020

机译：Latanoprostene BunodTimolol Mateate和Latanoprost眼科溶液的比较评估评估其在降低开放角度荧光眼管理的内部压力下的安全性和功效
7. Comparison of Latanoprostene Bunod 0.024 and Timolol Maleate 0.5 in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study [O] . Medeiros Felipe A., Martin Keith R., Peace James, 2016

机译：LUNAR研究比较开角型青光眼或高眼压中Latanoprostene Bunod 0.024％和Timolol Maleate 0.5％

Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

著录项

相似文献

相关主题

期刊订阅